IL17A and pulmonary arterial hypertension: After 1 year of PAH-specific therapy, proportions of IL-17+ CD4+ T cells, Th17 and Tc17 cells were increased, whereas CTLA4 expression on both CD4+ and CD8+ T cells was concomitantly decreased in IPAH patients.